BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

North America

Turn Bio Acquires ARMMs Technology to Advance Precision Epigenetic Therapies Across More Tissues and Indications

ARMMs brings precision medicine through targeted, non-viral vesicular delivery Synergy of ARMMs and eTurna™ LNP platforms means company can delive...

March 27, 2025 | News

AnHorn Medicines Doses First Subject in U.S. Phase I Trial for AH-001, a First-in-Class Protein Degrader Targeting Hair Loss

AnHorn Medicines, a pioneering AI-driven new drug discovery company, is pleased to announce that, AH-001, a first-in-class protein degrader for androg...

March 27, 2025 | News

Complete Genomics and BioTuring Partner to Accelerate Spatial Transcriptomics with AI-Powered Analysis Tool

Complete Genomics, a leading innovator in genomic sequencing, announced at the NextGen Omics & Spatial Biology Conference that it has pa...

March 26, 2025 | News

Alamar Biosciences Launches NULISAseq Mouse Panel 120 to Power Precision Biomarker Discovery in Preclinical Research

Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, is proud to announce the launch of the NULISAseq M...

March 26, 2025 | News

Sermonix and Regor Therapeutics Forge Strategic Alliance to Advance Targeted Therapies for Metastatic Breast Cancer

Sermonix Pharmaceuticals, a privately held biopharmaceutical company developing innovative therapeutics to specifically treat metastatic breast cancers (mB...

March 25, 2025 | News

VantAI Introduces Neo-1, the First Unified Model for De Novo Molecular Generation and Structure Prediction

Neo-1 is the first model to unify de novo molecular generation and atomic-level structure prediction in a single model, by generating latent representa...

March 24, 2025 | News

Telix Secures FDA Approval for Gozellix® to Expand PSMA-PET Imaging Access in Prostate Cancer

Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the United States (U.S.) Food and Drug Administrat...

March 21, 2025 | News

Advanced Instruments to Acquire Nova Biomedical, Creating a Global Life Science Tools Powerhouse

Patricia Industries' subsidiary Advanced Instruments, a manufacturer of analytical instruments for the biopharmaceutical and clinical markets, announ...

March 20, 2025 | News

Porton Advanced and Eureka Therapeutics Partner to Advance Next-Gen T-Cell Therapies

Porton Advanced, a leading contract development and manufacturing organization (CDMO) specializing in advanced therapy medicinal products (ATMPs), is pleas...

March 20, 2025 | News

SOPHiA GENETICS Surpasses Two Million Genomic Profiles Analyzed on AI-Powered Platform

SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and leader in data-driven medicine, has reached a historic milestone: more than two million...

March 19, 2025 | News

Azurity Pharmaceuticals Completes Acquisition of Covis Group, Expanding Global Footprint and Therapeutic Portfolio

Azurity Pharmaceuticals ("Azurity") announced the successful completion of its acquisition of Covis Group S.à r.l. ("Covis") from e...

March 17, 2025 | News

C2N Diagnostics Secures $10M Investment from Samsung to Expand Alzheimer’s Blood Biomarker Testing

-C2N Diagnostics, LLC (“C2N”), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, announced a $...

March 14, 2025 | News

Insilico Medicine Secures $110M Series E to Advance AI-Powered Drug Discovery and Clinical Innovations

Insilico Medicine("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, announced that it has successfully s...

March 14, 2025 | News

Celltrion Launches STEQEYMA®, a Biosimilar to STELARA®, in the U.S. at an 85% Lower WAC List Price

STEQEYMA®, one of the first-wave biosimilars to STELARA®, is now available in the U.S. Approved for the same indications as the reference produc...

March 13, 2025 | News

Stay Connected